Works citing this work

2 works

Work: The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

1. Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms

   Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4

   ArticleProtein Degradation and InhibitorsBiomolecules20262 citations

   ABIABI:AkademIndex/openalex/2026.article.000038

2. Translational research of new developments in targeted therapy of colorectal cancer

   Lei Yang, N. E. Atakhanova, Meryelem Tania Churampi Arellano +9

   Review articleColorectal Cancer Treatments and StudiesPathology - Research and Practice20230 citations

   ABIABI:AkademIndex/openalex/2023.review-article.000055